Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Marques

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Frontiers in Immunology|September 7, 2021
Serological Testing for COVID-19, Immunological Surveillance, and Exploration of Protective AntibodiesLuis A Peroni, Jessica M Toscaro, Camila Canateli, et al.
Hepatology (Baltimore, Md.)|April 26, 2012
Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failurePedro E Marques, Sylvia S Amaral, Daniele A Pires, et al.
Plos Neglected Tropical Diseases|November 9, 2023
Influence of previous Zika virus infection on acute dengue episodeCassia F Estofolete, Alice F Versiani, Fernanda S Dourado, et al.
Cell Communication and Signaling : CCS|February 7, 2013
Altered responsiveness to extracellular ATP enhances acetaminophen hepatotoxicitySylvia S Amaral, André G Oliveira, Pedro E Marques, et al.
Mbio|April 27, 2017
<i>N</i>-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus InfectionVivian V Costa, Juliana L Del Sarto, Rebeca F Rocha, et al.
Journal of Virology|December 13, 2023
Gene duplication as a major force driving the genome expansion in some giant virusesTalita B Machado, Agnello C R Picorelli, Bruna L de Azevedo, et al.
Immunity|January 25, 2025
Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repairFederico F De Ponti, Anna Bujko, Zhuangzhuang Liu, et al.
The European Respiratory Journal|December 28, 2020
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trialPatricia R M Rocco, Pedro L Silva, Fernanda F Cruz, et al.
Viruses|November 27, 2021
Clusters of SARS-CoV-2 Lineage B.1.1.7 Infection after Vaccination with Adenovirus-Vectored and Inactivated VaccinesWilliam M de Souza, Stéfanie P Muraro, Gabriela F Souza, et al.
The Lancet. Microbe|July 14, 2021
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological studyWilliam M Souza, Mariene R Amorim, Renata Sesti-Costa, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Frontiers in Immunology|September 7, 2021
Serological Testing for COVID-19, Immunological Surveillance, and Exploration of Protective AntibodiesLuis A Peroni, Jessica M Toscaro, Camila Canateli, et al.
Hepatology (Baltimore, Md.)|April 26, 2012
Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failurePedro E Marques, Sylvia S Amaral, Daniele A Pires, et al.
Plos Neglected Tropical Diseases|November 9, 2023
Influence of previous Zika virus infection on acute dengue episodeCassia F Estofolete, Alice F Versiani, Fernanda S Dourado, et al.
Cell Communication and Signaling : CCS|February 7, 2013
Altered responsiveness to extracellular ATP enhances acetaminophen hepatotoxicitySylvia S Amaral, André G Oliveira, Pedro E Marques, et al.
Mbio|April 27, 2017
<i>N</i>-Methyl-d-Aspartate (NMDA) Receptor Blockade Prevents Neuronal Death Induced by Zika Virus InfectionVivian V Costa, Juliana L Del Sarto, Rebeca F Rocha, et al.
Journal of Virology|December 13, 2023
Gene duplication as a major force driving the genome expansion in some giant virusesTalita B Machado, Agnello C R Picorelli, Bruna L de Azevedo, et al.
Immunity|January 25, 2025
Spatially restricted and ontogenically distinct hepatic macrophages are required for tissue repairFederico F De Ponti, Anna Bujko, Zhuangzhuang Liu, et al.
The European Respiratory Journal|December 28, 2020
Early use of nitazoxanide in mild COVID-19 disease: randomised, placebo-controlled trialPatricia R M Rocco, Pedro L Silva, Fernanda F Cruz, et al.
Viruses|November 27, 2021
Clusters of SARS-CoV-2 Lineage B.1.1.7 Infection after Vaccination with Adenovirus-Vectored and Inactivated VaccinesWilliam M de Souza, Stéfanie P Muraro, Gabriela F Souza, et al.
The Lancet. Microbe|July 14, 2021
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological studyWilliam M Souza, Mariene R Amorim, Renata Sesti-Costa, et al.
Pageof 17